MedPath

江西浩然生物制药有限公司

Ownership
-
Established
2008-02-22
Employees
-
Market Cap
-
Website
www.haoranbiopharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Chorionic Gonadotropin

Product Name
绒促性素
Approval Number
国药准字H20163128
Approval Date
Feb 3, 2021
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H44024874
Approval Date
Nov 6, 2019
NMPA

Chorionic Gonadotrophin for Injection

Product Name
注射用绒促性素
Approval Number
国药准字H44024875
Approval Date
Nov 6, 2019
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H22023409
Approval Date
Jun 25, 2019
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H22023407
Approval Date
Jun 25, 2019
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H22023406
Approval Date
Jun 25, 2019
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H22023408
Approval Date
Jun 25, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.